Why the study?
Following findings of protective effects of combining quercetin with sitagliptin in testicular tissue, this study evaluated the cardioprotective effects of quercetin and sitagliptin, alone or combined, in doxorubicin-induced cardiotoxicity in rats.
Does the combination of quercetin and sitagliptin prevent doxorubicin-induced cardiotoxicity in rats?
Population
Thirty male adult Wistar rats
Comparison
DOX with QC and STN, DOX with QC, DOX with STN, DOX alone, and control
Design
Five-group animal study
Follow-up
Day 22
Authors
Loading...
Hypothesis-generating for QC+STN in DOX cardiotoxicity; human trials needed before clinical consideration.
Does the combination of quercetin and sitagliptin prevent doxorubicin-induced cardiotoxicity in rats?
The combination of quercetin and sitagliptin demonstrates additive cardioprotective effects against doxorubicin-induced cardiotoxicity in a rat model.
Tavga Ahmed Aziz (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: